Total Debt for Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's latest reported total debt is $6.98B USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal DebtSwitch metric
Latest period
$6.98B
YoY change
-2.4%
5Y CAGR
+7.6%
Peak year (2024)
$7.09B
Latest annual
$6.92B
Total Debt history chart for Quest Diagnostics (DGX) from 1996 to 2025
Total Debt history table for Quest Diagnostics (DGX) from 1996 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $6.92B | -2.4% | ||
| 2024 | $7.09B | +28.9% | ||
| 2023 | $5.50B | +16.6% | ||
| 2022 | $4.71B | -1.2% | ||
| 2021 | $4.77B | -0.7% | ||
| 2020 | $4.81B | -11.2% | ||
| 2019 | $5.42B | +35.7% | ||
| 2018 | $3.99B | +3.5% | ||
| 2017 | $3.85B | +3.2% | ||
| 2016 | $3.73B | +2.3% | ||
| 2015 | $3.65B | -3.0% | ||
| 2014 | $3.76B | +12.9% | ||
| 2013 | $3.33B | -0.9% | ||
| 2012 | $3.36B | -16.4% | ||
| 2011 | $4.02B | +34.6% | ||
| 2010 | $2.99B | -3.8% | ||
| 2009 | $3.11B | +0.8% | ||
| 2008 | $3.08B | -12.9% | ||
| 2007 | $3.54B | +127.6% | ||
| 2006 | $1.56B | -2.3% | ||
| 2005 | $1.59B | +44.9% | ||
| 2004 | $1.10B | -0.3% | ||
| 2003 | $1.10B | +34.1% | ||
| 2002 | $822.54M | +0.1% | ||
| 2001 | $821.74M | -19.9% | ||
| 2000 | $1.03B | -15.7% | ||
| 1999 | $1.22B | +161.8% | ||
| 1998 | $464.80M | -9.7% | ||
| 1997 | $514.80M | -3.9% | ||
| 1996 | $535.79M | — |
Total Debt values are taken from Quest Diagnostics's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Quest Diagnostics (DGX) most recent annual total debt stands at $6.92B (2025) – edged down 2.4% year-over-year.
Quest Diagnostics total debt compound annual growth for the 2020–2025 (5 years) window is +7.6%, with the latest reading among the more recent periods of the dataset.
$7.09B stands as the all-time-high annual total debt, posted in 2024, against a low of $464.80M during 1998.
Quest Diagnostics (DGX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $52.57B.
Quest Diagnostics Total Debt by Year
Quest Diagnostics Total Debt 2025: $6.92B
Quest Diagnostics total debt in 2025 was $6.92B, edged down 2.4% below 2024.
Quest Diagnostics Total Debt 2024: $7.09B
Quest Diagnostics total debt in 2024 was $7.09B, grew 28.9% from 2023. This figure represents the highest annual value in the available history.
Quest Diagnostics Total Debt 2023: $5.50B
Quest Diagnostics total debt in 2023 was $5.50B, grew 16.6% from 2022.
Quest Diagnostics Total Debt 2022: $4.71B
Quest Diagnostics total debt in 2022 was $4.71B, edged down 1.2% below 2021.
Quest Diagnostics Total Debt 2021: $4.77B
Quest Diagnostics total debt in 2021 was $4.77B.
See more financial history for Quest Diagnostics (DGX).
Sector peers — Total Debt
Companies in the same sector as Quest Diagnostics, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is Quest Diagnostics's total debt?
- Latest reported total debt for Quest Diagnostics (DGX) is $6.98B (period ending March 31, 2026).
How has Quest Diagnostics total debt changed year-over-year?
- Quest Diagnostics (DGX) total debt changed -2.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Quest Diagnostics total debt?
- Quest Diagnostics (DGX) total debt compound annual growth rate is +7.6% over the most recent 5 years available.
When did Quest Diagnostics total debt hit its highest annual value?
- Quest Diagnostics total debt reached its highest annual value of $7.09B in 2024.
What was Quest Diagnostics total debt in 2024?
- Quest Diagnostics (DGX) total debt in 2024 was $7.09B.
What was Quest Diagnostics total debt in 2025?
- Quest Diagnostics (DGX) total debt in 2025 was $6.92B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DGX Overview
Company profile, financial tools, and key metrics
DGX Revenue Counter
Earns $357.62 every second. See per minute, hour, and day.
DGX Earnings Counter
Earns $32.47 per second net profit. See per minute, hour, and day.
DGX Economic Scale
Exceeds Monaco's GDP. Compare with world economies.
DGX What If Invested
What if you had invested $1,000? See historical returns from any date.
DGX How It Makes Money
Discover visual breakdown of $11.28B in revenue — where it comes from and where it goes.
DGX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DGX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DGX Daily Price Character
Steady · 50.6% historical win rate (green days). Streaks & record days.
DGX Buybacks
2.09% TTM buyback yield. Shareholder yield & SBC comparison.
DGX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
DGX Dividend Profile
Yield: 1.72%. Safety: 5/8. See full history.
DGX Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
DGX Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.